Pretreatment cytogenetics add to other prognostic factors predicting complete remission and long-term outcome in patients 60 years of age or older with acute myeloid leukemia: results from Cancer and Leukemia Group B 8461Sherif S. Farag, Clara D. Bloomfield, Mazin Β. Qumsiyeh et al.|Blood|2006Cited by 332
Ten-day decitabine as initial therapy for newly diagnosed patients with acute myeloid leukemia unfit for intensive chemotherapyBhavana Bhatnagar, Maria R. Baer, Vu H. Duong et al.|Leukemia & lymphoma/Leukemia and lymphoma|2013Cited by 56
Racial differences in presentation, referral and treatment patterns and survival in adult patients with acute myeloid leukemia: A single-institution experienceJason Bierenbaum, Maria R. Baer, Amy J. Davidoff et al.|Leukemia Research|2011Cited by 39
Activation of a novel palmitoyltransferase ZDHHC14 in acute biphenotypic leukemia and subsets of acute myeloid leukemiaLi Yu, Yi Ning, Ivana Gojo et al.|Leukemia|2010Cited by 35